ArchivIA Università degli Studi di Catania
 

ArchivIA - Archivio istituzionale dell'Universita' di Catania >
Tesi >
Tesi di dottorato >
Area 05 - Scienze biologiche >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10761/1036

Issue Date: 24-Feb-2012
Authors: Catania, Angela Maria
Title: Enhancement of efficacy and selectivity of chemopreventive compounds in human breast cancer cells by using immunoliposomes
Abstract: Trastuzumab targets the human epidermal growth factor receptor 2 (HER2), which is overexpressed in 20-30% of breast and ovarian cancers carrying a bad prognosis. Our purpose was to target HER2-overexpressing human breast cancer cells with pegylated immunoliposomes bearing trastuzumab and containing bioactive compounds. Using two breast cancer cell lines, with different HER2 expression levels, these immunoliposomes decreased cancer cells viability in a dose-response manner and in correlation to their level of HER2 expression.
Appears in Collections:Area 05 - Scienze biologiche

Files in This Item:

File Description SizeFormatVisibility
CTNNLM83B54B202Q-Tesi Angela Catania.pdfTesi Angela Catania3,84 MBAdobe PDFView/Open


Items in ArchivIA are protected by copyright, with all rights reserved, unless otherwise indicated.


Share this record
Del.icio.us

Citeulike

Connotea

Facebook

Stumble it!

reddit


 

  Browser supportati Firefox 3+, Internet Explorer 7+, Google Chrome, Safari

ICT Support, development & maintenance are provided by the AePIC team @ CILEA. Powered on DSpace Software.